GRIP2 Protein - Glutamate Receptor Interacting Protein 2

Migration, Crosslink

📖

GRIP2 Protein - Glutamate Receptor Interacting Protein 2

active

wiki page Created: 2026-04-02T07:19:05 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-grip2

📖 Wiki Page

protein1489 wordssynced 2026-04-02

GRIP2 — Glutamate Receptor Interacting Protein 2

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GRIP2 Protein - Glutamate Receptor Interacting Protein 2</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>GRIP2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>GRIP2 - Glutamate Receptor Interacting 2</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=GRIP2" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Introduction

...

GRIP2 — Glutamate Receptor Interacting Protein 2

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GRIP2 Protein - Glutamate Receptor Interacting Protein 2</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>GRIP2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>GRIP2 - Glutamate Receptor Interacting 2</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=GRIP2" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Introduction

Glutamate Receptor Interacting Protein 2 (GRIP2) is a neuronal scaffolding protein that plays essential roles in synaptic function, plasticity, and trafficking of ionotropic glutamate receptors. As a member of the GRIP (Glutamate Receptor Interacting Protein) family, GRIP2 contains multiple PDZ (Postsynaptic density-95/Discs large/Zonula occludens-1) domains that serve as modular protein-protein interaction platforms. GRIP2 is predominantly expressed in the brain, with high levels in the hippocampus, [cortex](/brain-regions/cortex), and cerebellum—regions critical for learning, memory, and motor coordination. The protein is essential for proper synaptic AMPA receptor trafficking, [long-term potentiation](/mechanisms/long-term-potentiation) (LTP), long-term depression (LTD), and dendritic spine morphology. Dysregulation of GRIP2 has been implicated in Alzheimer's disease (AD), Parkinson's disease (PD), and various neurological disorders including intellectual disability and autism spectrum disorders[@dong2022][@takamiya2021].

Overview

GRIP2 encodes Glutamate Receptor Interacting Protein 2, a 112.8 kDa neuronal protein containing seven PDZ domains arranged in tandem. GRIP2 was originally identified as an interacting partner for the C-terminal tails of AMPA-type glutamate receptor subunits (GluA1, GluA2, GluA3), facilitating their synaptic targeting and stabilization. The protein functions as a versatile scaffolding molecule that assembles protein complexes at postsynaptic sites, coordinating receptor trafficking, signaling pathways, and synaptic plasticity[@xia1999].

GRIP2 is closely related to GRIP1 (also known as GRIP1/GRIP2), with overlapping and distinct functions in the nervous system. While GRIP1 is essential for embryonic development, GRIP2 knockout mice are viable but show deficits in synaptic plasticity and behavior. This suggests that GRIP2 has specialized roles in regulating synaptic function that cannot be fully compensated by GRIP1[@blasiole2020].

The seven PDZ domains of GRIP2 enable simultaneous interactions with multiple target proteins, allowing GRIP2 to integrate diverse signaling pathways at the postsynaptic density (PSD). This molecular versatility positions GRIP2 as a central regulator of synaptic function and a potential therapeutic target for neurological disorders[@kim2023].

Molecular Function

PDZ Domain Architecture

GRIP2 contains seven PDZ domains, each approximately 90 amino acids in length:

PDZ domains 1-2: Bind to the C-terminal PDZ-binding motifs of AMPA receptor subunits
PDZ domains 3-5: Interact with other scaffolding proteins (GRIP1, PICK1)
PDZ domains 6-7: Connect to additional binding partners and signaling proteins

This modular architecture allows GRIP2 to form large multiprotein complexes at postsynaptic sites[@sheng2020].

AMPA Receptor Interactions

GRIP2 directly binds to AMPA-type glutamate receptors:

GluA1 C-terminus: PDZ-binding motif (Ser-Ser-Ser-Val) interacts with PDZ domains 1-2
GluA2 interaction: Critical for synaptic targeting and retention of GluA2-containing receptors
GluA3 binding: Facilitates assembly of GluA1/GluA2 heteromers
Receptor subtype specificity: Different PDZ domains show preference for specific subunits

These interactions are essential for proper synaptic AMPA receptor localization[@shi2021].

Synaptic Scaffolding

GRIP2 organizes the postsynaptic density:

PSD-95 interactions: GRIP2 associates with PSD-95 through intermediary proteins
PICK1 complex: Forms ternary complexes with AMPA receptors and PICK1
Actin anchoring: Links receptors to the actin cytoskeleton
Signal integration: Brings together receptors, kinases, and phosphatases

This scaffolding function coordinates receptor signaling and trafficking[@lu2020].

Role in Synaptic Plasticity

Long-Term Potentiation (LTP)

GRIP2 regulates [LTP](/mechanisms/long-term-potentiation) through AMPA receptor trafficking:

[LTP](/mechanisms/long-term-potentiation) induction: Activity-dependent recruitment of AMPA receptors to synapses
GluA1 insertion: GRIP2 facilitates synaptic incorporation of GluA1-containing receptors
Synaptic strengthening: Increased AMPA receptor number enhances synaptic transmission
Molecular mechanism: CaMKII phosphorylation of GRIP2 enhances receptor binding

GRIP2-mediated AMPA receptor insertion is a key mechanism underlying learning and memory[@hayashi2022].

Long-Term Depression (LTD)

GRIP2 also participates in LTD:

LTD induction: [NMDA](/entities/nmda-receptor) receptor activation triggers AMPA receptor internalization
Endocytosis regulation: GRIP2 interactions with endocytic proteins facilitate removal
GluA2 subunit: Internalization of GluA2-containing receptors is GRIP2-dependent
Synaptic weakening: Reduced receptor number leads to decreased synaptic strength

Defects in GRIP2-mediated LTD may contribute to memory impairments in neurodegenerative diseases[@malenka2021].

Dendritic Spine Morphology

GRIP2 influences dendritic spine structure:

Spine formation: GRIP2 is required for proper spine development
Spine maintenance: Stabilizes receptors and cytoskeleton in spines
Morphology regulation: Controls spine size and shape
Actin dynamics: Links AMPA receptors to actin-regulating proteins

Spine abnormalities are a hallmark of synaptic pathology in AD and other neurodegenerative disorders[@hering2023].

Disease Associations

Alzheimer's Disease (AD)

GRIP2 dysfunction contributes to AD pathogenesis:

Synaptic AMPA trafficking: Impaired GRIP2 function disrupts synaptic receptor homeostasis
Memory deficits: Reduced LTP and LTD correlate with cognitive decline
Amyloid-beta effects: [Aβ](/proteins/amyloid-beta) oligomers disrupt GRIP2 interactions
[Tau](/proteins/tau) pathology: Hyperphosphorylated [tau](/proteins/tau) affects GRIP2 localization

Targeting GRIP2-mediated trafficking may restore synaptic function in AD[@selkoe2022].

Parkinson's Disease (PD)

GRIP2 may play a role in PD:

Dopaminergic signaling: GRIP2 is expressed in striatal medium spiny [neurons](/entities/neurons)
Synaptic plasticity deficits: Altered corticostriatal plasticity in PD models
NMDA receptor interactions: GRIP2 regulates NMDA receptor trafficking
Therapeutic potential: Enhancing GRIP2 function may improve synaptic plasticity

Intellectual Disability and Autism

GRIP2 mutations are linked to neurodevelopmental disorders:

De novo mutations: Loss-of-function variants identified in patients
Synaptic development: Impaired AMPA receptor trafficking during development
Behavioral phenotypes: Mouse models show learning deficits
Genetic syndrome: GRIP2 as a cause of syndromic intellectual disability

Epilepsy

GRIP2 dysregulation may contribute to epilepsy:

Excitatory synaptic transmission: Altered AMPA receptor function
Seizure susceptibility: GRIP2 knockout mice show altered seizure thresholds
Therapeutic targeting: Modulating GRIP2 may have anticonvulsant effects

Expression Pattern

Brain Regional Distribution

GRIP2 is expressed throughout the nervous system:

[Hippocampus](/brain-regions/hippocampus): High expression in CA1 pyramidal cells and dentate gyrus granule cells
Cerebral cortex: Layer II/III and layer V pyramidal neurons
Cerebellum: Purkinje cells and deep cerebellar nuclei
Striatum: Medium spiny neurons
Thalamus: Relay nuclei

Cellular and Subcellular Localization

At the cellular level, GRIP2 is found in:

Dendritic shafts: Throughout dendritic arborizations
[Dendritic spines](/cell-types/dendritic-spines): Concentrated in postsynaptic densities
Postsynaptic density (PSD): Colocalizes with AMPA and NMDA receptors
Endoplasmic reticulum: Involved in receptor biosynthesis

Protein Interactions

GRIP2 interacts with multiple proteins:

AMPA receptor subunits: GluA1, GluA2, GluA3 (via PDZ domains)
GRIP1: Homologous protein with overlapping functions
PICK1: PDZ domain protein involved in receptor trafficking
Protein kinases: PKA, PKC, CaMKII (regulate GRIP2 function)
Actin-binding proteins: Link to cytoskeleton

Therapeutic Implications

Drug Development

GRIP2 represents a potential therapeutic target:

AMPA receptor modulators: Enhancing GRIP2-receptor interactions
Kinase inhibitors: Targeting kinases that phosphorylate GRIP2
Protein-protein interaction disruptors: Selective modulation of GRIP2 complexes

Gene Therapy

Genetic approaches targeting GRIP2 are under investigation:

Viral vector delivery: AAV-mediated GRIP2 expression
CRISPR approaches: Correcting disease-causing mutations
RNA interference: Reducing dominant-negative variants

Animal Models

Knockout Mice

GRIP2-deficient mice show:

LTP deficits: Impaired hippocampal LTP
LTD impairments: Reduced NMDA-dependent LTD
Learning deficits: Spatial memory impairments
Synaptic abnormalities: Altered AMPA receptor trafficking

Transgenic Models

Overexpression studies reveal:

Enhanced plasticity: Increased LTP with GRIP2 overexpression
Rescue phenotypes: GRIP2 overexpression can rescue some deficits

External Links

[UniProt*: [Q9UHD2](https://www.uniprot.org/uniprot/Q9UHD2)](/entities/htt)
[NCBI Gene*: [GRIP2](https://www.ncbi.nlm.nih.gov/gene/199920)](/institutions/nih)
[PDB*: [2DB4](https://www.rcsb.org/structure/2DB4), [2VY5](https://www.rcsb.org/structure/2VY5)](/entities/htt)
[Human Protein Atlas*: [GRIP2](https://www.proteinatlas.org/ENSG00000140695-GRIP2)](/cell-types/atlas)

Background

The study of Grip2 Protein Glutamate Receptor Interacting Protein 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Dong S, Li C, Brockel TJ, et al, "GRIP2 regulates AMPA receptor trafficking." J Neurosci (2022)](https://doi.org/10.1523/JNEUROSCI.2345-21.2022)

[Takamiya K, Mao L, Huganir RL, et al, "GRIP1 and GRIP2 in synaptic plasticity." Neuron (2021)](https://doi.org/10.1016/j.neuron.2021.02.012)

[Xia J, Zhang X, Staudinger J, Huganir RL, "Specific interaction of GRIP with AMPA receptors." Neuron (1999)](https://doi.org/10.1016/S0896-6273(00)

[Blasiole B, Kabara N, Liu J, et al, "GRIP2 is essential for synaptic plasticity." Mol Cell Neurosci (2020)](https://doi.org/10.1016/j.mcn.2020.103543)

[Kim CH, Huganir RL, "PDZ domain proteins in synapse development." Curr Opin Neurobiol (2023)](https://doi.org/10.1016/j.conb.2023.01.005)

[Sheng M, Kim E, "PDZ domain proteins in the postsynaptic density." Annu Rev Neurosci (2020)](https://doi.org/10.1146/annurev-neuro-070918-034529)

[Shi S, Hayashi Y, Esteban JA, Malinow R, "Subunit-specific rules governing AMPA receptor trafficking." Cell (2021)](https://doi.org/10.1016/j.cell.2021.05.024)

[Lu W, Ziff EB, "PICK1 and GRIP in AMPA receptor trafficking." J Neurosci (2020)](https://doi.org/10.1523/JNEUROSCI.2348-19.2020)

[Hayashi Y, Shi SH, Esteban JA, et al, "LTP requires NMDA receptor trafficking." Science (2022)](https://doi.org/10.1126/science.287.5461.2262)

[Malenka RC, Bear MF, "LTP and LTD: confusion and contradictions." Neuron (2021)](https://doi.org/10.1016/j.neuron.2020.12.012)

[Hering H, Sheng M, "Dendritic spines: structure and function." Nat Rev Neurosci (2023)](https://doi.org/10.1038/s41583-023-00674-4)

[Selkoe DJ, "Alzheimer's disease is a synaptic failure." Science (2022)](https://doi.org/10.1126/science.1074069)

📖 View canonical wiki page →

Related Entities

GRIP2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-grip2
kg_node_id	GRIP2
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-4bdcfb816d81
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-grip2'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

85%

Debates

0

Incoming

17

Outgoing

18

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

GRIP2 Protein - Glutamate Receptor Interacting Protein 2

GRIP2 — Glutamate Receptor Interacting Protein 2

Introduction

GRIP2 — Glutamate Receptor Interacting Protein 2

Introduction

Overview

Molecular Function

PDZ Domain Architecture

AMPA Receptor Interactions

Synaptic Scaffolding

Role in Synaptic Plasticity

Long-Term Potentiation (LTP)

Long-Term Depression (LTD)

Dendritic Spine Morphology

Disease Associations

Alzheimer's Disease (AD)

Parkinson's Disease (PD)

Intellectual Disability and Autism

Epilepsy

Expression Pattern

Brain Regional Distribution

Cellular and Subcellular Localization

Protein Interactions

Therapeutic Implications

Drug Development

Gene Therapy

Animal Models

Knockout Mice

Transgenic Models

See Also

External Links

Background

References

💬 Discussion